Joint Symposiums
LTSI – iLDLT Joint Symposium
Day 2 | 21st November 2025 | Hall A
Navigating from the Operating Table to the Surgeons Console
Overview
The LTSI – iLDLT Joint Symposium on Robotic Recipient Surgery for Liver Transplant aims to provide a focused academic platform for the exchange of knowledge and experience in this rapidly advancing field. It will address the technical evolution, clinical feasibility, and outcomes of robotic approaches in liver transplant recipient surgery.
Learning Objectives
- Ways to optimize outcome and success by mastering patient selection.
- Understand the paradigm of robotic recipient surgery — what lies ahead.
Patient Selection: Selecting the best candidate for robotic recipient surgery
The Robotic Recipient Hepatectomy: Evolving Steps and Tricks
Implantation and Beyond: Key Steps and the Tricks
The Recipient Surgery – Are we pushing the envelope too fast?
Joint LTSI–ISVIR 2025 Symposium
Day 2 | 21st November 2025 | Hall C
Transarterial Radioembolization in Liver Tumors: Expanding Horizons in Locoregional Therapy
Overview
This comprehensive joint session by the Liver Transplant Society of India (LTSI) and the Indian Society of Vascular and Interventional Radiology (ISVIR) will focus on the expanding role of Transarterial Radioembolization (TARE) in the management of primary and metastatic liver tumors.
The symposium will cover the full spectrum of TARE—from foundational principles and patient selection to technical execution and post-treatment assessment. Participants will gain practical insights into the integration of TARE within multidisciplinary liver cancer care, as well as its emerging applications as a bridge or downstaging therapy for liver tumors.
Learning Objectives
- Understand the principles, indications, and patient selection for TARE.
- Review the technical aspects of pre-procedure work-up, dosimetry, and microsphere delivery.
- Discuss imaging strategies for mapping, simulation, and post-procedure follow-up.
- Identify complications, troubleshooting methods, and rescue strategies.
- Examine future directions, including combination approaches with immuno-oncology therapies.
Setting the Stage : How TARE is reshaping Liver Cancer Therapy
The role of TARE in downstaging for major liver resection and transplantation
From Clinic to Cath Lab : A Stepwise Approach to TARE Work-Up
Implementing Precision Dosimetry in Resource-Limited Settings
Voxel-based dosimetry - The new standard?
Technical Pearls in Radioembolization : Lessons From the Angio Suite
Bhabhaspheres : India's Indigenous Y-90 Solution for TARE
Same-Day TARE : Safety, Logistics, and Patient-Centric Care
Complications in Radioembolization : Recognition, Prevention, and Management
Panel Discussion - Achieving Consensus on Y-90 therapies in complex scenarios: MDT- the way forward
LTSI – ILTS Joint Symposium
Day 3 | 22nd November 2025 | Hall A
Science Behind the Scalpel – Basic Science Research in Liver Transplantation
Overview
The LTSI–ILTS Joint Symposium bridges the gap between basic science and clinical application in liver transplantation. It explores how molecular biology, immunology, and experimental modeling are reshaping patient outcomes and innovation.
Learning Objectives
- Introduce key basic science concepts relevant to liver transplantation.
- Highlight how experimental models and omics tools solve clinical problems.
- Foster clinician–scientist collaboration and translational research.
Innate vs adaptive immune changes, tolerance pathways, role of T cells
Oxidative stress, inflammasomes, cytokine storms, mitigation strategies
Microbiome shifts post-transplant, metabolomics insights
Integrating Basic Science Research with Clinical Practice
Joint LTSI–INASL Symposium
Day 4 | 23rd November 2025 | Hall A
Navigate ALF with Precision: Etiological Patterns, ICU Care, Dynamic Scores, and Transplant Readiness
Overview
This collaborative session by the Indian National Association for the Study of the Liver (INASL) and the Liver Transplant Society of India (LTSI) brings together hepatologists, intensivists, and transplant specialists to provide an integrated perspective on the management of Acute Liver Failure (ALF).
The symposium will explore the etiological spectrums of ALF in different clinical settings, contemporary approaches to intensive care and the application of dynamic prognostic scores in guiding timely and effective interventions. Special emphasis will be placed on transplant readiness—including early identification of candidates, optimizing pre-transplant stabilization, and streamlining referral pathways to improve survival outcomes.
By combining insights from medical hepatology and transplant science, this joint session highlights the importance of precision, collaboration, and early decision-making in improving outcomes for patients with ALF.
Learning Objectives
- Discuss recent changes in etiological pattern of ALF.
- To learn about dynamics and outcomes of hyperacute ALF.
- Managing ALF intraoperative surgical and anaesthetic perspectives.
Changing etiological patterns of ALF in India
Drug induced ALF: Role and Timing of Liver Transplant
Case-Based Panel Discussion: 27 F with HAV related hyperacute ALF admitted in liver ICU: care/monitoring/ALSS/Tx Listing
Sub topics:
ALF in emergency department – Things to do
ICU care of ALF patient (when to MV, ICP monitoring, Nutrition, Antibiotics/antifungals of choice)
Artificial liver support system (Plasma exchange/CRRT) – Patient selection, prevention of infections, CRRT first or plasma exchange – how to decide
Does Dynamic scores help in deciding for Liver Transplant listing
Scores in ALF: Is KCC still relevant for selecting ALF for Liver Transplantation
Surgical Strategies in Acute liver failure
Perioperative Management of patient with Acute Liver Failure: An Anaesthesiologist's Perspective
